Core Viewpoint - Hexcel's shares have increased by approximately 11.1% since the last earnings report, but this performance is still below that of the S&P 500 [1] Estimates Movement - Estimates for Hexcel have trended downward over the past month, with a consensus estimate shift of -8.64% [2] VGM Scores - Hexcel currently holds an average Growth Score of C, a Momentum Score of D, and a Value Score of C, resulting in an aggregate VGM Score of D, placing it in the middle 20% for investment strategies [3] Outlook - The downward trend in estimates suggests a negative outlook for Hexcel, reflected in its Zacks Rank of 4 (Sell), indicating expectations of below-average returns in the coming months [4]

Core Viewpoint - Olema Pharmaceuticals, Inc. (OLMA) shows significant upside potential with a mean price target of $24.71, indicating a 386.4% increase from the current price of $5.08 [1] Price Targets - The average price target consists of seven estimates ranging from a low of $18 to a high of $30, with a standard deviation of $4.64, suggesting variability in analyst opinions [2] - The lowest estimate indicates a potential increase of 254.3%, while the highest suggests a 490.6% upside [2] - A low standard deviation indicates a higher agreement among analysts regarding price movement [9] Analyst Sentiment - Analysts are optimistic about OLMA's earnings prospects, as indicated by a positive trend in earnings estimate revisions [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 25.4%, with five estimates moving higher and no negative revisions [12] Zacks Rank - OLMA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting strong potential for upside [13]

Wall Street analysts expect Semtech (SMTC) to post quarterly earnings of $0.38 per share in its upcoming report, which indicates a year-over-year increase of 533.3%. Revenues are expected to be $249.79 million, up 21.2% from the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Ahead of a company's earnings disclosure, it is cru ...

Core Viewpoint - Analysts project Ralph Lauren (RL) will report quarterly earnings of $1.96 per share, a 14.6% increase year over year, with revenues expected to reach $1.63 billion, reflecting a 4.1% increase from the same quarter last year [1] Earnings Estimates - The consensus EPS estimate has been revised 0.2% lower over the last 30 days, indicating a collective reevaluation by analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3] Revenue Projections - Analysts estimate 'Net revenues- Retail' at $1.01 billion, suggesting a year-over-year increase of 6.7% [5] - 'Net revenues- Wholesale' are projected to reach $585.58 million, indicating a 0.9% increase from the previous year [5] - 'Geographic Net revenues- Other- Licensing' is expected to be $35.47 million, reflecting a decrease of 3.4% year over year [5] Geographic Revenue Estimates - 'Geographic Net revenues- North America' are anticipated to be $685.16 million, a 2.6% increase from the year-ago quarter [6] - 'Geographic Net revenues- Europe' are projected at $493.24 million, suggesting a 5.1% year-over-year increase [6] - 'Geographic Net revenues- Asia' are expected to reach $420.67 million, indicating a 6.7% increase year over year [6] Stock Performance - Ralph Lauren shares have returned 32.9% over the past month, outperforming the Zacks S&P 500 composite's 13.1% change [7] - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to mirror overall market performance in the near future [7]

Core Viewpoint - SkyWater Technology, Inc. (SKYT) shows significant potential for upside, with a mean price target of $11 indicating a 35% upside from its current price of $8.15, following a 23.7% gain over the past four weeks [1]. Price Targets and Analyst Consensus - The average price targets from analysts range from a low of $8 to a high of $12, with a standard deviation of $1.73, indicating variability in estimates. The lowest estimate suggests a decline of 1.8%, while the highest points to a 47.2% upside [2]. - A low standard deviation among price targets suggests strong agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [9]. Earnings Estimates and Analyst Optimism - Analysts have shown growing optimism regarding SKYT's earnings prospects, as indicated by a positive trend in earnings estimate revisions. This trend has a strong correlation with near-term stock price movements [11]. - Over the last 30 days, two earnings estimates for SKYT have been revised upward, leading to a 20.8% increase in the Zacks Consensus Estimate [12]. Zacks Rank and Investment Potential - SKYT holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, which further supports its potential for upside [13].

Core Viewpoint - The upcoming earnings report for Zoom Communications is anticipated to show a decline in earnings per share while revenues are expected to increase slightly year over year [1]. Financial Performance - Quarterly earnings are projected at $1.30 per share, reflecting a decrease of 3.7% compared to the same period last year [1]. - Revenue is forecasted to reach $1.16 billion, indicating a year-over-year increase of 2% [1]. - There has been a downward revision of 0.4% in the consensus EPS estimate over the past 30 days, suggesting analysts have adjusted their projections [2]. Revenue Breakdown - Geographic Revenue from Asia Pacific (APAC) is estimated at $143.01 million, representing a 3.6% increase from the previous year [5]. - Geographic Revenue from Europe, Middle East, and Africa (EMEA) is expected to be $184.58 million, showing a 0.3% increase year over year [5]. - Geographic Revenue from the Americas is projected at $838.48 million, indicating a 2.4% increase from the prior year [6]. Customer Metrics - The number of Enterprise Customers is estimated to be 193,166, up from 191,000 in the same quarter last year [6]. - Customers generating more than $100K in TTM Revenue are expected to reach 4,155, compared to 3,883 in the same quarter of the previous year [7]. Performance Obligations - Current Remaining Performance Obligation (RPO) is projected at $2.33 billion, up from $2.18 billion in the same quarter last year [7]. - Remaining Performance Obligations (RPO) are expected to be $3.86 billion, compared to $3.67 billion in the same quarter last year [8]. - Non-Current Remaining Performance Obligation (RPO) is estimated at $1.51 billion, slightly up from $1.49 billion year over year [8]. Stock Performance - Zoom shares have increased by 17.3% over the past month, outperforming the Zacks S&P 500 composite, which rose by 9.8% [8].

Core Insights - Analysts project Medtronic (MDT) will report quarterly earnings of $1.58 per share, an increase of 8.2% year over year, with revenues expected to reach $8.81 billion, up 2.6% from the same quarter last year [1] Earnings Estimates - The consensus EPS estimate for the quarter has remained unchanged over the past 30 days, indicating analysts' reassessment of their initial projections [1][2] Revenue Projections - The consensus estimate for 'Net Sales- World Wide Revenue- Diabetes' is $700.27 million, reflecting a year-over-year change of +6.1% [3] - 'Net Sales- World Wide Revenue- Neuroscience' is forecasted to reach $2.55 billion, indicating no change year over year [4] - 'Net Sales- World Wide Revenue- Cardiovascular' is expected to be $3.27 billion, showing a +4.6% change from the previous year [4] - 'Net Sales- World Wide Revenue- Medical Surgical' is estimated at $2.27 billion, with a year-over-year change of +3.1% [4] U.S. Revenue Estimates - 'Net Sales- U.S. Revenue' is projected at $4.49 billion, suggesting a +3.3% year-over-year change [5] - 'Net Sales- U.S. Revenue- Medical Surgical' is expected to reach $966.71 million, indicating a +1.3% change from the prior year [5] International Revenue Estimates - 'Net Sales- ROW- Neuroscience- Cranial & Spinal Technologies' is estimated at $363.81 million, reflecting a +2.5% change year over year [6] - 'Net Sales- ROW- Neuroscience- Specialty Therapies' is projected to be $346.44 million, indicating a +2.2% change [6] - 'Net Sales- ROW- Medical Surgical- Surgical & Endoscopy' is expected to be $1.02 billion, with a -0.5% change year over year [7] - 'Net Sales- ROW- Cardiovascular' is forecasted at $1.74 billion, showing a +3.3% change from the previous year [7] - 'Net Sales- ROW- Cardiovascular- Coronary & Peripheral Vascular' is projected to reach $383.12 million, indicating a +3.8% change [8] Stock Performance - Medtronic shares have returned +4.3% over the past month, compared to the Zacks S&P 500 composite's +9.8% change, with a Zacks Rank 3 (Hold) indicating expected performance in line with the overall market [8]

Core Insights - Analysts expect Wix.com (WIX) to report quarterly earnings of $1.66 per share, reflecting a year-over-year increase of 28.7% [1] - Revenue projections stand at $471.78 million, which is a 12.4% increase from the same quarter last year [1] - The consensus EPS estimate has been adjusted downward by 0.2% over the past 30 days, indicating a reassessment by analysts [1] Revenue Estimates - 'Revenues - Business Solutions' are projected to reach $135.06 million, marking a 17% increase from the prior-year quarter [4] - 'Revenues - Creative Subscriptions' are expected to be $336.71 million, reflecting a 10.7% increase from the previous year [4] Key Metrics - 'Creative Subscriptions ARR' is anticipated to reach $1.38 billion, up from $1.24 billion reported in the same quarter last year [5] - 'Total Bookings - Business Solutions' are expected to be $142.88 million, compared to $122.64 million in the prior year [5] - 'Total Bookings - Creative Subscriptions' is projected at $368.37 million, an increase from $334.64 million reported last year [6] Profit Estimates - 'Non-GAAP Gross Profit - Business Solutions' is estimated at $42.66 million, up from $34.58 million in the same quarter last year [6] - 'Non-GAAP Gross Profit - Creative Subscriptions' is forecasted to reach $283.35 million, compared to $252.16 million reported in the previous year [7] Stock Performance - Wix.com shares have increased by 14.5% over the past month, outperforming the Zacks S&P 500 composite, which rose by 9.8% [7]

Wall Street analysts forecast that Target (TGT) will report quarterly earnings of $1.68 per share in its upcoming release, pointing to a year-over-year decline of 17.2%. It is anticipated that revenues will amount to $24.42 billion, exhibiting a decline of 0.5% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 5.7% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections ...

Core Insights - Analysts expect Palo Alto Networks (PANW) to report quarterly earnings of $0.77 per share, reflecting a year-over-year increase of 16.7% [1] - Revenue is anticipated to reach $2.27 billion, marking a 14.6% increase from the same quarter last year [1] - The consensus EPS estimate has been revised 0.1% lower in the last 30 days, indicating a reevaluation of initial estimates by analysts [1][2] Revenue Projections - Analysts predict 'Revenue- Product' to be $418.98 million, indicating a year-over-year change of +7.2% [4] - The estimate for 'Revenue- Subscription and support' is $1.86 billion, suggesting a change of +16.4% year over year [4] - The 'Revenue- Subscription and support- Support' is estimated at $598.89 million, reflecting a +9.3% change from the prior-year quarter [4] Subscription Metrics - The average prediction for 'Revenue- Subscription and support- Subscription' is $1.25 billion, indicating a year-over-year change of +20% [5] - Analysts estimate 'Remaining Performance Obligation (RPO)' to reach $13.54 billion, up from $11.3 billion reported in the same quarter last year [5] Profit Projections - 'Product gross profit Non-GAAP' is projected to be $329.84 million, compared to $316.60 million in the same quarter last year [6] - 'Subscription and support gross profit Non-GAAP' is expected to reach $1.43 billion, up from $1.22 billion reported in the same quarter last year [6] Stock Performance - Palo Alto shares have increased by +12.5% in the past month, outperforming the Zacks S&P 500 composite's +9% [6] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to closely follow overall market performance in the near term [6]